United States · Series B startup

Who invested in VentaoRX

One round we have observed, with the 3 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

BiotechHealthcare

Funding summaryUpdated 26 Oct 2026

$42Mraised across 1 round since 2017, from 1 source

Latest round
Series B, $42MAug 2017
Investors
3
See who backed them

The rounds

  1. Aug 2017
    Series B$42M

    Reported by FinSMEs

Everyone who backed them

BioAdvanceVC firm1round
ForesiteVC firm1round
Versant Ventures/ Abingworthno record of our own yet1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about VentaoRX

Who invested in VentaoRX?

VentaoRX's investors include BioAdvance, Foresite and Versant Ventures/ Abingworth.

How much has VentaoRX raised?

VentaoRX has raised $42M across 1 round since 2017.

When did VentaoRX last raise?

VentaoRX's most recent round was a Series B of $42M in Aug 2017.

What was VentaoRX's biggest round?

Its most recent round, $42M in Aug 2017, is also its largest on record.

Who backed VentaoRX first?

VentaoRX's first round on record, in Aug 2017, was backed by BioAdvance, Foresite and Versant Ventures/ Abingworth.

What stage is VentaoRX at?

VentaoRX's latest named round is a Series B, in Aug 2017.

Where is VentaoRX based?

VentaoRX is based in the United States.

Companies like VentaoRX

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.